Next generation sequencing technologies to address aberrant mRNA translation in cancer
- PMID: 38751936
- PMCID: PMC11094761
- DOI: 10.1093/narcan/zcae024
Next generation sequencing technologies to address aberrant mRNA translation in cancer
Abstract
In this review, we explore the transformative impact of next generation sequencing technologies in the realm of translatomics (the study of how translational machinery acts on a genome-wide scale). Despite the expectation of a direct correlation between mRNA and protein content, the complex regulatory mechanisms that affect this relationship remark the limitations of standard RNA-seq approaches. Then, the review characterizes crucial techniques such as polysome profiling, ribo-seq, trap-seq, proximity-specific ribosome profiling, rnc-seq, tcp-seq, qti-seq and scRibo-seq. All these methods are summarized within the context of cancer research, shedding light on their applications in deciphering aberrant translation in cancer cells. In addition, we encompass databases and bioinformatic tools essential for researchers that want to address translatome analysis in the context of cancer biology.
© The Author(s) 2024. Published by Oxford University Press on behalf of NAR Cancer.
References
Publication types
LinkOut - more resources
Full Text Sources
